Delivery Order SPE2DB22D1002-SPE2DB25FLGA5
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $15,961.88 by the Medical Supply Chain, a defense-focused federal agency, for the supply of Ketorolac 30 mg/mL vials. This firm fixed price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug commonly used for pain management...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vials valued at $1,163.76 on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-competitive delivery order placed under the company's existing indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,295.97 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed-price contract structure. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation. This award represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,163.76. The contract is firm fixed price and is classified as a non-set-aside award, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $2,605.10 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-competitive, non-set-aside procurement of this pharmaceutical product. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 60 mg/2 mL vials, with a ceiling value of $1,750.87. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 4, 2025, and represents a small-value pharmaceutical procurement typical of federal medical supply operations. The delivery will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,357.72, is a firm fixed-price delivery order for the supply of Ketorolac 30 mg/mL vials. The contract has a period of performance through June 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials, with a ceiling value of $3,879.20. The contract, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating open competitive award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Ketorolac 10 mg tablets (100-count units) valued at $1,182.51. This firm fixed-price delivery order, issued on July 31, 2025, represents a non-set-aside award under open competition and is scheduled for completion by August 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,378.40 firm-fixed-price contract is for the delivery of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLGA5Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for the supply of Ketorolac 30 mg/ml vials. The contract, issued on August 8, 2025, carries a ceiling value of $1,279.84 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems and demonstrates extensive capability in fulfilling diverse pharmaceutical supply requirements through its established federal contracting relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/8/25 |